BIOMAT Database Logo BIOMAT Database Logo

[Clofibrate-induced muscle problems]. 1979

G Bojs, and M Fahlén, and L Lapidus

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Bojs, and M Fahlén, and L Lapidus
Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy.
April 1977, The New England journal of medicine,
G Bojs, and M Fahlén, and L Lapidus
Clofibrate and muscle.
November 1968, Lancet (London, England),
G Bojs, and M Fahlén, and L Lapidus
Clofibrate-induced muscle damage in patients with chronic renal failure.
December 1975, Lancet (London, England),
G Bojs, and M Fahlén, and L Lapidus
Clofibrate-induced antidiuresis.
March 1973, The Journal of clinical investigation,
G Bojs, and M Fahlén, and L Lapidus
Muscle syndrome with clofibrate usage.
July 1974, Connecticut medicine,
G Bojs, and M Fahlén, and L Lapidus
No muscle damage from clofibrate.
January 1969, The New England journal of medicine,
G Bojs, and M Fahlén, and L Lapidus
No muscle damage from clofibrate.
January 1969, The New England journal of medicine,
G Bojs, and M Fahlén, and L Lapidus
Clofibrate, calcium and cardiac muscle.
March 1982, Archives internationales de pharmacodynamie et de therapie,
G Bojs, and M Fahlén, and L Lapidus
Clofibrate-induced ventricular arrhythmia.
February 1969, The American journal of cardiology,
G Bojs, and M Fahlén, and L Lapidus
Clofibrate, serum enzymes, and muscle pain.
April 1970, British medical journal,
Copied contents to your clipboard!